10X Genomics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.4% | 14.3% | 14.3% | 29.5% | 26.1% | 26.9% | 25.3% | 22.0% | 21.0% | 23.4% | 20.1% | 16.8% | 16.1% | 4.2% | 19.6% | 19.2% | 22.3% | 24.2% | 23.2% | 23.6% | 26.7% | 32.2% | 37.8% | 37.1% | 34.1% | 31.9% | 29.8% | 32.8% | 31.9% | 27.7% | 32.7% | 31.9% | 29.6% | 25.5% | 30.0% | |
| 85.6% | 85.7% | 85.7% | 70.5% | 73.9% | 73.1% | 74.7% | 78.0% | 79.0% | 76.6% | 79.9% | 83.2% | 83.9% | 95.8% | 80.4% | 80.8% | 77.7% | 75.8% | 76.8% | 76.4% | 73.3% | 67.8% | 62.2% | 62.9% | 65.9% | 68.1% | 70.2% | 67.2% | 68.1% | 72.3% | 67.3% | 68.1% | 70.4% | 74.5% | 70.0% | |
| 50.0% | 36.1% | 30.3% | 25.9% | 27.9% | 32.3% | 36.3% | 37.0% | 36.1% | 64.2% | 42.0% | 35.4% | 39.6% | 46.1% | 43.6% | 43.1% | 56.0% | 61.7% | 51.3% | 40.7% | 50.0% | 48.7% | 70.2% | 35.5% | 48.7% | 41.1% | 43.6% | 40.6% | 41.5% | 35.4% | 38.4% | 33.7% | 37.7% | 37.6% | 36.8% | |
| 70.5% | 66.5% | 52.2% | 51.8% | 50.2% | 58.4% | 53.3% | 49.5% | 70.1% | 103.5% | 71.8% | 48.2% | 53.8% | 59.3% | 49.5% | 45.4% | 58.2% | 69.2% | 56.0% | 48.1% | 62.0% | 62.3% | 53.6% | 45.0% | 60.8% | 54.2% | 53.9% | 54.5% | 57.9% | 43.0% | 50.6% | 46.1% | 44.0% | 52.1% | 48.1% | |
| 121.1% | 103.3% | 82.5% | 79.1% | 78.1% | 90.7% | 89.6% | 88.7% | 106.6% | 168.4% | 170.8% | 448.1% | 93.5% | 104.7% | 93.1% | 91.8% | 114.2% | 130.9% | 107.3% | 91.2% | 112.0% | 111.0% | 123.9% | 92.9% | 109.5% | 95.3% | 97.5% | 97.4% | 93.5% | 54.9% | 89.0% | 79.9% | 81.7% | 87.4% | 84.4% | |
| -24.8% | -17.2% | -40.8% | -148.3% | -5.7% | -18.6% | -14.9% | -10.7% | -27.7% | -91.9% | -90.9% | -365.0% | -9.7% | -8.9% | -12.7% | -11.0% | -36.5% | -55.1% | -30.5% | -14.8% | -38.7% | -43.2% | -61.7% | -30.0% | -43.6% | -27.3% | -27.4% | -30.2% | -25.4% | 17.4% | -21.6% | -11.8% | -11.3% | -12.9% | -14.3% | |
| – | – | 1.8% | 1.4% | 1.3% | 1.2% | 1.2% | 1.3% | 0.9% | 0.7% | 0.6% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | – | |
| -36.5% | -18.6% | -41.9% | -149.3% | -6.7% | -19.4% | -15.7% | -9.3% | -29.0% | -92.6% | -90.9% | -364.1% | -10.5% | -8.6% | -13.3% | -11.1% | -36.4% | -55.7% | -30.5% | -10.5% | -37.0% | -41.4% | -59.7% | -25.3% | -41.0% | -24.2% | -22.7% | -29.3% | -21.6% | 21.4% | -18.9% | -9.2% | -8.5% | -12.3% | -12.1% | |
| 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.4% | 1.0% | 0.8% | 6.2% | 0.4% | 0.9% | 0.4% | 1.7% | 0.6% | 0.5% | 1.4% | 0.5% | 0.8% | 1.1% | 0.8% | 1.3% | 1.5% | 0.5% | 0.9% | 0.4% | 0.6% | 1.4% | -0.5% | 0.6% | 0.4% | -0.5% | 0.0% | |
| -36.5% | -18.7% | -41.9% | -149.4% | -6.8% | -19.5% | -15.7% | -9.5% | -29.4% | -93.6% | -91.7% | -370.3% | -10.9% | -9.5% | -13.7% | -12.9% | -37.0% | -56.2% | -32.0% | -11.0% | -37.8% | -42.5% | -60.5% | -26.6% | -42.5% | -24.8% | -23.6% | -29.7% | -22.2% | 20.0% | -18.4% | -9.8% | -8.9% | -11.9% | -12.2% | |
| -51.6% | -13.8% | -40.1% | -147.9% | -3.5% | -18.1% | -11.2% | -4.2% | -22.1% | -81.5% | -83.5% | -359.0% | -4.2% | -2.2% | -7.3% | -5.9% | -29.3% | -48.2% | -24.3% | -5.0% | -30.5% | -33.3% | -52.3% | -19.0% | -32.8% | -17.1% | -15.6% | -22.9% | -15.3% | 27.0% | -10.7% | 38.3% | -0.6% | -12.3% | 4.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.